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ABSTRACT: Biopolymer-based multilayers become more and
more attractive due to the vast span of biological application they
can be used for, e.g., implant coatings, cell culture supports,
scaﬀolds. Multilayers have demonstrated superior capability to
store enormous amounts of small charged molecules, such as drugs,
and release them in a controlled manner; however, the binding
mechanism for drug loading into the multilayers is still poorly
understood. Here we focus on this mechanism using model
hyaluronan/polylysine (HA/PLL) multilayers and a model charged
dye, carboxyﬂuorescein (CF). We found that CF reaches a
concentration of 13 mM in the multilayers that by far exceeds its solubility in water. The high loading is not related to the
aggregation of CF in the multilayers. In the multilayers, CF molecules bind to free amino groups of PLL; however, intermolecular
CF−CF interactions also play a role and (i) endow the binding with a cooperative nature and (ii) result in polyadsorption of CF
molecules, as proven by ﬁtting of the adsorption isotherm using the BET model. Analysis of CF mobility in the multilayers by
ﬂuorescence recovery after photobleaching has revealed that CF diﬀusion in the multilayers is likely a result of both jumping of
CF molecules from one amino group to another and movement, together with a PLL chain being bound to it. We believe that
this study may help in the design of tailor-made multilayers that act as advanced drug delivery platforms for a variety of
bioapplications where high loading and controlled release are strongly desired.
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■ INTRODUCTION
The layer-by-layer deposition of polyelectrolyte multilayers has
become very popular in the last decades due to its simplicity,
low cost, automation, and reproducibility.1−7 The method is
based on sequential deposition of oppositely charged polymers
onto a solid surface.1,3−7 Physical−chemical properties of the
multilayers can easily be adjusted to meet various requirements
by proper choice of preparation conditions, variation of
polyelectrolyte chain length and nature, and postmodiﬁca-
tion.8−11 Furthermore, the multilayers have attracted signiﬁcant
attention, since they have been shown to serve as good
candidates for a number of bioapplications.2,12−24 The planar
multilayers (ﬁlms) and curved structures (capsules) mostly play
the role of hosting reservoirs and releasing numerous
biologically active molecules, such as nucleic acids, proteins,
and peptides.2,25−30 Recently, a number of reports appeared to
demonstrate the high capacity of multilayers to host small
molecules, including drugs and dyes.31−33 This makes the
multilayers very attractive as biocoatings (e.g., implant
coatings) that host bioactive drugs (antibiotics, anticancer
drugs, small biofactors such as growth factors, cytokines, etc.)
and release them in a controlled manner, for instance, through
erosion or biodegradation.
One of the most commonly used methods for loading
biomolecules of interest into the multilayers is the incubation of
the as-prepared multilayers in a solution of the bioactive agent.
Simple dyes are often used as model molecules to mimic the
behavior of a real drug. Additionally, model dyes such as
carboxyﬂuorescein (CF) or rhodamine can be directly
monitored by ﬂuorescence or absorbance. In some cases, the
capacity of a multilayer to store a dye is determined by the
nature of the last polyelectrolyte layer deposited.34 Fluores-
cently labeled paclitaxel was homogeneously distributed
throughout multilayers composed from hyaluronic acid (HA)
and poly-L-lysine (PLL).33 Likewise, it was possible to load the
anti-inﬂammatory drug diclofenac into cross-linked multilayers,
and the amount of the stored drug can be tuned by the
multilayer thickness/number of layers.35 Furthermore, the same
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study showed that paclitaxel loaded into multilayers was
eﬀective in killing cells with an eﬃciency of about 90%.
Variation of the number of layers aﬀects both the loading and
release rate of the loaded molecules.36
High water content in the biopolymer-based multilayers,
along with their structural properties, allows one to load large
macromolecules such as proteins (albumin, lysozyme,
others)28,37 and nucleic acids.29,30 Full exploitation of these
ﬁlms for bioapplications (cell culture and tissue engineering)
requires that these systems should oﬀer a controlled release of
the stored molecules. The trigger for the release can be a
change in the physical−chemical properties of the multilayers
or environment changes: temperature, pH, composition, ionic
strength, hydrolysis, and light.38−43 These stimuli can be
employed for both short-term31 and long-term44 release.
Though the possibilities for applications and control over
loading and release performance are countless, the mechanism
of storage/release of small molecules/drugs in the multilayers is
still not well understood and a number of reports on loading
and release of small drugs show high interest for this
topic.32−34,36,45,46
It has recently been demonstrated that small charged dyes
can be loaded into the biopolymer-based multilayers in
enormous concentrations.47 This concerns not only model
dyes such as CF and rhodamine but also biologically relevant
small charged molecules like adenosine triphosphate (ATP),
which is of particular interest due to its well-known role in
bioenergy storage and conversion. A number of reports focus
on investigation of ATP loading and release into/from surface
ﬁlms employing the energy of ATP hydrolysis,48 electrochemi-
cally stimulated release,49 ATP-induced self-assembly,50 and
loading into layered double hydroxides through intercalation of
ATP and other nucleotides.51 More complex self-assembled
ATP-containing structures based on metal nanoparticles and
block copolymers with bioinspired binding units have also been
reported.52,53
The multilayers that have been given enormous attention as a
model system are assembled from model biopolymers HA and
PLL. These ﬁlms can easily reach up to a few micrometers in
thickness or even tens of micrometers due to their exponential-
like growth character,54−57 and thus they oﬀer considerable
reservoir capacity.47 HA/PLL multilayers can be used as
supports for cell culture.58,59 Bearing in mind their high storage
capability, these multilayers are perfect candidates as drug
delivery systems for cellular applications. However, in order to
comprehend their delivery potential, it is of immense
importance to understand the mechanism by which a drug is
withheld in the multilayers.
In this paper we focus on the binding mechanism of the
small, charged, ﬂuorescent dye CF to the HA/PLL multilayers
assembled by the dipping technique. Spectral characteristics of
CF along with its mobility and adsorption equilibrium capacity
in the multilayers are analyzed and used as major indicators for
assessment of CF binding to multilayers. We ﬁrmly believe that
a better understanding of the binding mechanism of small dyes
such as CF could be used to design novel, eﬀective, polymer-
based systems with tuned loading and release characteristics
required for cutting-edge drug delivery and tissue-engineering
applications.
■ MATERIALS AND METHODS
Chemicals. Sodium hyaluronate (HA; 360 kDa, #HA500 K) was
purchased from Lifecore Biomedical and Hellmanex II (#9-307-010-
507) from Hellma GmbH. Poly-L-lysine hydrobromide (PLL; 15−30
kDa, #P7890), polyethylenimine (PEI; 110 kDa, #306185), 5(6)-
carboxyﬂuorescein (CF; #21877), TRIS, NaCl, and HCl were supplied
by Sigma-Aldrich. All chemicals were used as received, without further
puriﬁcation.
Assembly of HA/PLL Multilayers. HA/PLL ﬁlms were
assembled on 12 mm round glass slides using an automated dip-
coating machine according to the protocol described elsewhere.59
Brieﬂy, after washing with Hellmanex II, 14 mm round glass slides
were immersed for 10 min in 1 mg/mL PEI, followed by washing in 10
mM TRIS buﬀer containing 15 mM NaCl, pH 7.4 (referred to as
TRIS-buﬀer) three times. After that slides were immersed for 10 min
in 0.5 mg/mL HA, washed three times in the buﬀer, immersed in 0.5
mg/mL PLL, and again washed three times in the buﬀer. The HA/
PLL deposition step was repeated 24 times. The ﬁlms were always
terminated with PLL as the outermost layer.
Loading the Multilayers with CF and Analysis of CF
Fluorescence. Loading of HA/PLL multilayers was achieved by
incubating the HA/PLL in 1 mL of a 1 μM solution of CF in TRIS-
buﬀer in darkness for 24 h. The loading eﬃciency and released amount
of the loaded compound were determined by analysis of the
ﬂuorescence of the supernatant.
Fluorescence emission spectra of CF solutions in pure buﬀer and in
the buﬀer containing PLL were taken at 492 nm excitation. The
concentration of CF was kept ﬁxed at either 5 or 300 μM, and the PLL
concentration was varied to obtain diﬀerent ratios between the
number of lysine units (Mr = 209) in PLL and the CF molecules
(molar charge PLL:CF ratio). Furthermore, ﬂuorescence emission
spectra of CF loaded in the (HA/PLL)24 multilayers were determined;
the multilayers were loaded with CF by incubation in 1 μM CF. The
measurement was done at 1 and 60 min after immersion of the
multilayers into the TRIS-buﬀer in the cuvette; the moment of
immersion is considered as the start of the release.
Real-time observation of the loading was done by online
measurement of CF ﬂuorescence in solution where the (HA/PLL)24
multilayers were incubated. The experiment was done in quad-
ruplicate. The amount of CF loaded in the multilayers was determined
as the diﬀerence in the amount of CF measured in aliquots taken from
the solution with the multilayers and the control one (without the
multilayers; bar coverslip used instead).
Analysis of CF Diﬀusion in Multilayers by Fluorescence
Recovery after Photobleaching. The diﬀusion coeﬃcient and the
amount of immobile fraction were assessed by evaluation of data
resulting from the ﬂuorescence recovery after photobleaching (FRAP)
experiment. In general, the photobleaching may have an eﬀect on the
chemical structure of a ﬂuorescent dye that may aﬀect its interaction
with its surroundings. However, FRAP is well-accepted method to
assess the mobility of ﬂuorescent probes like CF, and this is why we
used this method in this study. The experimental procedure and the
data evaluation procedure were similar to procedures described
elsewhere60 but using planar multilayers. Glass slides with deposited
multilayers containing CF were mounted into a holder, covered by a
layer of TRIS-buﬀer to protect them from drying, and placed under a
confocal laser scanning microscope (Zeiss LSM 510 meta/Axiovert
200M). Using a 63×/1.4 objective the sample was bleached by the 488
nm laser line of an Ar ion laser at its full power and scanned by highly
attenuated laser power. The scanning area spanned 73.12 × 73.12 μm
(512 × 512 pixels) and the bleached area spanned 73.12 × 2.14 μm
(512 × 15 pixels). The proper z-position was determined as the
position of the highest intensity of the ﬂuorescence signal. The sample
was primarily scanned twice, afterward bleached (by scanning the laser
50 times over the bleached area, resulting in a dip of the ﬂuorescence
signal), and then again scanned 30 times. The time span between
following images was 2 s, and the scanning time per pixel was 3.2 μs.
The evaluation procedure of the acquired data was based on an
analytical solution of Fickian diﬀusion.61 The evaluation of the
immobile fraction amount is based on analysis of the dip depth as a
function of time. The measurements were repeated six times. The
details of the evaluation procedure are given below.
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The raw images from the FRAP experiment were primarily cropped
(to limit edge eﬀects) and averaged (ImageJ, NIH) in the direction
perpendicular to the direction of diﬀusion. The resulting one-
dimensional FRAP proﬁles were transferred into a spreadsheet
template (MS Excel) for data corrections and analysis. The set of
proﬁles resulting from a single FRAP experiment were normalized to
the prebleach ﬂuorescence intensity, corrected to the inhomogeneity
of the local ﬂuorescence, and corrected for unwanted bleaching and
edge eﬀects in the other dimension.
Every FRAP proﬁle is ﬁtted by a Gaussian curve deﬁned as
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where I(x,t) is the ﬂuorescence intensity at a distance x from the dip
and a time point after bleaching t, I0(t) is the ﬂuorescence intensity of
the background (ideally its value is constant and close to 1), A(t) is the
depth of the dip at the time point t, and w describes the width of the
Gaussian between inﬂection points. All four parameters are free for
ﬁtting with every separate FRAP proﬁle. The ﬁtting is performed as a
minimization of the sum of squared residuals. After ﬁtting the
Gaussian function into FRAP proﬁles, the diﬀusion coeﬃcient D is
evaluated as half of the slope of the plot of w2 versus t:
=D w
t2
2
(2)
Only the ﬁrst three points of this plot were used for slope
evaluation, because the plot tends to deviate when more than one
fraction (e.g., immobile fraction) is present. No change over time of
the w2 (not equal to zero) would indicate the presence of the
immobile fraction because of no recovery of the stable ﬂuorescent
proﬁle. The slope is inﬂuenced already from the onset of the recovery
process; thus, the resulting D rather represents an average diﬀusion
coeﬃcient.
The dimensionality of diﬀusion d may be evaluated as twice the
slope of the plot log(A) versus log(t + t0)
= − + +A d t tlog( )
2
log( ) const0 (3)
where the newly appeared parameter t0 refers to a time shift correcting
deviations from the approximation of instantaneous bleaching of an
inﬁnitely thin region. The time shift can be found by varying its value
until the plot log(A) versus log(t + t0) becomes linear (here
implemented as a maximization of the coeﬃcient of determination of
an expected linear function). Because also this plot tends to deviate
when more than one fraction is present, only the ﬁrst 10 points of the
plot were used for evaluation of d.
The relative amount of the immobile fraction Krel is evaluated from
the time development of the dip depth A(t) by ﬁtting the function
π
=
+
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where A(t) is the depth of the dip at time point t, M is the overall
reduction of the ﬂuorescence intensity caused by bleaching, D is the
diﬀusion coeﬃcient, t is time after bleaching, t0 is the time shift
correction, d is the dimensionality of diﬀusion, and K is the partial
depth of the dip attributed to the immobile fraction. D and d were
taken from the previous evaluation and ﬁxed during ﬁtting. These
values tend to be underestimated due to the inﬂuence of the immobile
fraction, but their presence is essential during ﬁtting for a good
estimation of the amount of immobile fraction. The d value used here
is bottom-limited to a value of 1, because values lower than 1 do not
reﬂect reality. M, t0, and K are free for ﬁtting. The input values A(t) are
acquired directly from the FRAP proﬁles, not from ﬁtting the Gaussian
function, because the evaluation of the immobile fraction is intended
to be independent from the evaluation of D as much as possible.
Afterward, Krel is obtained by relating K to the depth of the dip just
after bleaching
=K K
A t( )rel 0 (5)
where Krel stands for the relative amount of the immobile fraction, K is
the depth of the dip attributed to the immobile fraction resulting from
eq 4, and A0(t) is the depth of the dip just after bleaching (t = 0).
Such an approach to the evaluation of the immobile fraction
amount expects that only two fractions are present in the sample: a
single mobile fraction with certain D and an immobile one. In other
cases, the evaluation of the immobile fraction amount gives
approximate results. When the amount of the immobile fraction is
known, a contribution of this fraction can be subtracted from raw
FRAP proﬁles. The evaluation procedure can then be repeated with
the FRAP proﬁles free of immobile fraction. Results of this repeated
evaluation describe the pure mobile fraction rather than a mixture of
the mobile and the immobile fractions.
■ RESULTS AND DISCUSSION
Spectral Characteristics of CF in Solution and in the
HA/PLL Multilayers. Our previous study has demonstrated
that CF can be loaded into (HA/PLL)24 multilayers in TRIS-
buﬀer giving high concentrations in the multilayers of at least a
few millimolar.47 Incubation of excess CF with the multilayers
(at concentrations up to 100 μM) under the same conditions
has revealed that the saturation concentration of CF in the
multilayers is 13 mM. This is far more than the CF solubility in
the same buﬀer (about 0.5 mM).
In this work, we focus on the mechanism of binding of CF to
multilayers in order to explain the strong accumulation of CF in
the multilayers. The molecular structures of CF and PLL and
HA biopolymers used to build the multilayers are presented in
Figure S1 of the Supporting Information (SI). The dye CF
possesses a carboxylic group that is deprotonated at the
physiological pH and potentially allows the dye to interact with
charged polymers through electrostatic attractive forces. Thus,
throughout all experiments in this study, TRIS-buﬀer
containing a rather low concentration of added salt (15 mM)
and possessing the physiologically relevant pH 7.4 has been
used. A low salt concentration is needed to ensure that
electrostatic interactions between CF and permanent charges
on the polymer backbone are not screened by salt counterions.
In order to investigate the interaction of CF with multilayers,
ﬂuorescent spectra of CF have been taken in the presence of
the polymers from which the multilayers are made, PLL and
HA. Figure S2A (SI) demonstrates that HA has no eﬀect on the
maximum of CF ﬂuorescence and that the presence of PLL
results in a shift of the maximum of ﬂuorescence from 512 nm
(without PLL) to 514.5 nm (0.5 mg/mL PLL solution). This
can be explained by electrostatic binding of the oppositely
charged CF to amino groups of PLL and no electrostatic
interaction between CF and HA, which both carry a negative
charge. A variation of the PLL:CF molar charge ratio has shown
that the red-shift of the ﬂuorescence maximum (from 512 to
515.5 nm) takes place at a PLL:CF molar charge ratio of more
than 5 (Figure S2B, SI). The conditions of a high excess of PLL
can simulate those in the multilayers, where PLL may be in
much higher excess compared to CF because of the high
concentration of PLL in the multilayers, which can be estimated
as 250 mM taking into account that the multilayers have about
80% of water, that the molar charge ratio between PLL and HA
is about 2, and that 46% of amino groups of PLL is free, i.e.,
unpaired with HA.62
Apart from the binding of CF to amino groups of the PLL,
CF is prone to aggregation, due to its core hydrophobic part of
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the molecule. Considering this, one can propose three potential
models of CF binding to multilayers, as shown in Figure 1. The
model A suggests that only CF−CF interactions take place in
the multilayers. This may be reasonable because the CF
concentration in the multilayers by far surpasses the solubility
of CF in buﬀer, as discussed above. Such a high concentration
may be explained by formation of CF aggregates if one assumes
that the CF−CF interaction is stronger than the CF−PLL
interaction. Contrary to the ﬁrst model, model B assumes that
the energy gain for formation of CF−PLL is higher than that of
the CF−CF interaction and suggests that no aggregate
formation occurs and that CF is solely bound to PLL and is
also homogeneously distributed throughout the ﬁlm. The third
model C is basically a combination of the previous two models
A and B and is based on the assumption that both CF−CF and
CF−PLL interactions take place.
Further, the CF-loaded multilayers and CF solutions have
been analyzed to reveal which model can better describe the
mechanism of binding of CF to the multilayers. Fluorescence
spectra of CF in the buﬀer, CF loaded in the multilayers, and
CF released from the multilayers are shown in Figure 2. One
can compare the emission maximum of the spectra and take it
as a measure of CF aggregation and/or CF−PLL interaction.
About 70% of CF stored in the multilayers is released after 1 h
incubation in a fresh buﬀer solution.47 Therefore, we have
analyzed the CF spectra in the multilayers at the beginning of
the release process (1 min incubation in the buﬀer), when
almost all CF molecules should still be present in the
multilayers, and after 1 h of incubation, when the majority of
CF molecules have already left the multilayers (Figure 2A).
One can see that CF molecules stored in the ﬁlm have an
identical emission maximum, regardless of the incubation time
point, and it is about 516 nm. In comparison, CF released to
the buﬀer has the maximum emission of 512 nm. This
wavelength is similar to that of free CF in solution at a rather
low CF concentration of 1 μM and is the same as in the stock
solution used in this experiment for CF loading into the
multilayers (Figure 2B). However, a CF solution at the higher
concentration of 500 μM gives an emission maximum of 525
nm, indicating an eﬀect of the CF concentration on the
ﬂuorescence emission maximum.
These ﬁndings allow one to conclude that CF released from
the multilayers is in a free state (nonaggregated); however, in
the multilayers its emission maximum is shifted to higher
wavelengths of about 516 nm. To understand the reason for the
shift, we have considered the eﬀect of CF concentration on its
emission maximum more in detail. Figure 2C shows that an
increase of CF concentration in solution results in a progressing
red-shift of emission maximum up to 525 nm. This is obviously
because of CF−CF interactions, i.e., formation of CF
aggregates in solution.63,64 CF is becoming insoluble in
TRIS-buﬀer at concentration of more than 500 μM.
The results discussed above and presented in Figure 2 clearly
show that although the concentration of CF in the ﬁlm is in the
range of a few millimolar, it has an emission maximum at 516
nm, much below 525 nm, which is the emission maximum of
less concentrated 0.5 mM CF saturated solution in buﬀer.
Additionally, there are no other peaks identiﬁed for CF stored
in the ﬁlm, apart from that at 516 nm, meaning that only one
CF population is present. It would then not be misleading to
conclude that there are no pure CF aggregates in the
multilayers. This means that the ﬁrst model A (Figure 1) is
not feasible and that it is either model B or C.
In order to assess the strength of CF−PLL and CF−CF
interactions and make it reﬂective of the CF microenvironment
in the multilayers, we have performed experiments in solution
Figure 1. Schematic illustration of the three models (A−C) representing binding of CF to the HA/PLL multilayers. (A) CF forms aggregates within
multilayers, (B) CF is solely bound to amino groups of PLL and is equally distributed throughout the multilayers, and (C) CF is primarily bound to
PLL but CF−CF interactions takes place.
Figure 2. (A) Fluorescence spectra of CF-laden (HA/PLL)24 multilayers incubated in TRIS-buﬀer for 1 and 60 min. (B) Fluorescence spectra of 1
and 500 μM CF solution in TRIS-buﬀer as well as CF released from multilayers after 60 min incubation in the buﬀer. (C) Fluorescence emission
maximumum as a function of CF concentration in TRIS-buﬀer.
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where highly concentrated CF solution (0.3 mM, a
concentration comparable to that in the multilayers) has been
titrated with PLL (Figure 3). With no PLL present (at zero
PLL:CF molar charge ratio), the maximum emission of CF is
about 525 nm, caused by CF aggregation as discussed above
(Figure 2C). The wavelength maximum of emission pro-
gressively increases to about 547 nm until the molar charge
ratio of 5. At a higher molar ratio, the emission maximum
decreases back to about 530 nm (at the molar charge ratio of
42). The measured ﬂuorescence intensity behaves oppositely,
having a minimum at the PLL:CF molar ratio of 5.
The results obtained are explained schematically in the ﬁgure
above the graph in Figure 3. Addition of positively charged PLL
induces an interaction between the negatively charged CF
aggregates, making the aggregates larger. This increases the
number of CF−CF interactions, which results in a signiﬁcant
reduction of ﬂuorescence due to self-quenching of CF
molecules and a signiﬁcant increase of the red-shift of the
ﬂuorescence emission maximum. Both the red-shift and self-
quenching are phenomena related to intermolecular CF−CF
interactions, i.e., between π-electrons of CF molecules.63,64 At
the PLL:CF molar charge ratio of more than 5, the high excess
of PLL results in destruction of the formed aggregates and
formation of the PLL−CF complex. This, in turn, enhances the
ﬂuorescence and reduces the red-shift due to disruption of CF
aggregates. A PLL:CF molar charge ratio higher than 42 has
not been tested because of the need for a highly concentrated
PLL solution, but we hypothesize that at a higher PLL
concentration the red-shift will be further reduced down to the
emission maximum of 516 nm, as has been found for PLL−CF
complex at low CF concentration but high PLL excess (Figure
S2B, SI).
The results above allow one to conclude that PLL−CF
interaction should dominate with an excess of charged amino
groups of PLL compared to carboxylic ones for CF. This is
what most likely happens in the multilayers loaded with CF,
because in the multilayers the concentration of overall charges
of PLL (about 250 mM) signiﬁcantly exceeds the concentration
of CF (13 mM). According to the results presented above, it
can be concluded that the CF binding in the multilayers can be
described by models B or C (Figure 1). At the same time, the
CF environment in the PLL solution and inside the multilayers
may be diﬀerent (e.g., due to the presence of HA), and further
analysis of CF−multilayer binding has been performed to better
understand the binding mechanism and reveal the model of the
binding (Figure 1).
Figure 3. Dependence of the emission maximum and ﬂuorescence
intensity of a mixture of PLL and CF at diﬀerent PLL:CF molar charge
ratios. The interrupted vertical blue line represents the threshold at
which the spectral features are reversed. Schematics above the graph
demonstrate the proposed mechanism of binding of CF and PLL at
increased PLL:CF molar charge ratios.
Figure 4. (A and D) Fluorescence images of CF-loaded multilayers at 0 and 60 s after photobleaching, respectively. (B and E) Fluorescence recovery
proﬁles corresponding to the images A and D, respectively (perpendicular to the bleached back area in the images). The proﬁles are presented in
blue and the ﬁtted Gaussian functions in red. (C) Graph showing the evaluation of diﬀusion coeﬃcient (D). D is determined as half of the slope of
the ﬁrst three points of the plot w2 versus t (squared width of dip versus time). At later times, the curve starts to deviate from the initial trend because
of the presence of an immobile fraction. (F) A graph presenting evaluation of the amount of immobile fraction. The relative dip depth is plotted
against time. Afterward a function describing this relationship (red) is ﬁtted into the experimental data (blue) and extrapolated to inﬁnity to get the
amount of immobile fraction. Of note, small black spots in the images A and D are artifacts and are not related to the FRAP procedure.
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Analysis of CF Diﬀusion into the Mutilayers. A series of
FRAP experiments have been conducted to check the mobility
of CF in the ﬁlm. This may help to explain the interaction of
CF and PLL. The mean CF diﬀusion coeﬃcient (DCF) and the
amount of immobile CF fraction were estimated from these
experiments (Figure 4). The resulting diﬀusion coeﬃcient is an
average diﬀusion coeﬃcient of all CF fractions presented in our
sample and was found to be 1.3 ± 0.6 μm2/s. The amount of
immobile fraction refers to the CF fraction that seems to be
immobile on the time scale of our experiment (D < 0.01 μm2/
s). The immobile fraction was found to be about 9 ± 10% of
the total CF presented in the multilayers. One can compare the
found DCF in multilayers and D of PLL analyzed by a similar
FRAP approach.65 The mean DCF is similar to the DPLL for the
fastest PLL fraction, which is about 1 μm2/s. Three PLL
diﬀusive fractions were found in the multilayers.65 Slower
fractions of PLL have also been identiﬁed, but their
contribution into the mean DPLL measured will not be
signiﬁcant because the second diﬀusive fraction is much slower
(about 0.1 μm2/s) than the fastest one. The third fraction of
PLL is immobile (D below 0.001 μm2/s), but its content in the
multilayers (30−40%) is much higher than that for CF found
here (9%).
The results above suggest that CF diﬀusion in the multilayers
is most probably a result of both (i) free diﬀusion of CF
through jumping of CF molecules from one PLL backbone to
another and (ii) diﬀusion of CF molecules together with PLL
chains (bound to the PLL backbone). These results
corroborate well with our previous ﬁndings based on analysis
of CF release from multilayers as a function of the multilayer
properties.47
To further understand the binding of CF to the multilayers,
the kinetics of CF interaction with the multilayers has been
assessed at increased CF concentrations (Figure S3, SI). From
Table 1. Comparison of Six Adsorption Models66 Used To Fit Adsorption Isotherms for CF Loading into (HA/PLL)24
Multilayers (Figure 5)a
model mathematical eq ﬁtted parameters R2
Langmuir = +
C
C KC
KC1film
film max sol
sol
K = 0.35 ± 0.13 0.538
Freundlich =C KC nfilm sol1/ K = 224 ± 210 0.899
n = 0.5 ± 0.1
Langmuir−Freundlich =
+
C
C KC
KC
( )
1 ( )
n
nfilm
film max sol
1/
sol
1/ K = (1.4 ± 1.8) × 10
−4 0.854
n = 0.19 ± 0.12
Temkin = +C A C Blnfilm sol A = 3924 ± 895 0.767
B = 724 ± 258
sigmoidal Langmuir = + +
C
C KC
KC S C1 /film
film max sol
sol sol
K = (3.8 ± 0.2) × 104 0.737
S = (3.6 ± 2.8) × 105
BET = + − −
C
C KC C
C K C C C( ( 1) )( )film
mono sol sat
sat sol sat sol
Cmono = 1909 ± 787 μM 0.966
K = 27 ± 8
Csat = 7.5 ± 0.4 μM
aCsol is the concentration of CF in solution; Cfilm is the concentration of CF in the ﬁlm; Cfilm max is the maximum concentration of CF in the ﬁlm (this
parameter was ﬁxed for the ﬁtting procedure at 13.1 ± 1.2 mM based on the experimental results); Cmono is the maximum concentration of CF per
one deposited layer; Csat is the maximum concentration of CF in solution; and K, A, B, S, and n are parameters of the ﬁtting. Fitted parameters are
presented as the average ± SD for n = 4 experiments.
Figure 5. Fitting of the adsorption isotherm (SD are given for n = 4) obtained for CF loading into (HA/PLL)24 multilayers by (A) BET, Freundlich,
and Langmuir−Freundlich models and (B) Langmuir, sigmoidal Langmuir, and Temkin models.
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these results, the adsorption isotherms have been constructed
and ﬁtted by six well-known adsorption models based on
equilibrium adsorption process, i.e., Langmuir, Freundlich,
Langmuir−Freundlich, Temkin, sigmoidal Langmuir, and
Brunauer−Emmett−Teller (BET) models66 (Table 1). The
main characteristics of the models are summarized in Table S1
(SI). Brieﬂy, only the Langmuir model is based on the
assumption of formation of a monolayer (monoadsorption),
and all other models assume that each adsorbed molecule
provides a new binding site for another molecule to be
adsorbed. All other ﬁve polyadsorption models are based on the
assumption that either adsorbate (CF) molecules do not
interact with each other or the interaction of adsorbate (CF)
and adsorbent (HA/PLL ﬁlm) has a cooperative or competitive
nature. It is important to note that for these models only
Langmuir and BET equations (Table 1) can be derived on the
basis of statistical thermodynamics, while the other models are
empirical.
The data used for ﬁtting was the average of the quadruplicate
measurement. As the measure of the ﬁt we used the coeﬃcient
of determination (R2) in order to reveal the model that better
ﬁts the experimental results (R2 closest to a unit). R2 was
calculated using the equation for the general case
= −R 1 SS
SS
2 res
tot
where SSres is the sum of squared residuals, SSres = ∑i(yi − f i)2.
It is a parameter to be minimized during the ﬁtting procedure. y
stands for input data values, and f stands for predicted values.
SStot is the total sum of squares, SStot = ∑i(yi − yav)2. y stands
for input data values, and yav stands for the average value of
variable y in our sample. This parameter is proportional to the
variance of y.
It should be noted that the experimental adsorption isotherm
has a clearly deﬁned region of saturation (Figure 5). This was
taken into account by ﬁxing the parameter Cfilm max at 13.1 ± 1.2
mM. By the same token, Freundlich, Temkin, and BET
equations were ﬁtted until the saturation plateau.
Figure 5A presents the ﬁtting of experimental results of the
CF loading into the multilayers by the three above-mentioned
adsorption models that provided the best ﬁtting results
(correlation coeﬃcient R > 0.90), i.e., BET, Freundlich, and
Langmuir−Freundlich models. Adsorption isotherms for the
three other models (Langmuir, sigmoidal Langmuir, and
Temkin), which show R < 0.90, are given in Figure 5B.
The best ﬁt was found for the BET model (R2 = 0.966). This
indicates that the interaction of CF with (HA/PLL)24
multilayers is likely according to assumptions on which the
BET model is based. Considering the ﬁve general types of BET
adsorption isotherms that are known (Table S2, SI), CF
loading into the multilayers can be described in the best way by
the S-shaped type V adsorption isotherm. The S-type of
isotherm suggests cooperative adsorption, when the binding of
adsorbate molecules to the adsorbent depends on the
concentration of adsorbed molecules; in other words, binding
of two adsorbate molecules to the adsorbent is not
independent.67 The binding of one molecule increases the
aﬃnity for the binding of the next molecule.67 At the same
time, the type V BET isotherm refers to the polyadsorption of
CF molecules to equivalent binding cites. This means that each
CF molecule adsorbed to a PLL backbone provides a new site
for the adsorption of the molecule in the layer above it, and the
anchorage to two types of binding cites (NH3
+ group or CF
molecule) is characterized by the same or close adsorption
energies; i.e., binding sites within the ﬁlm are equivalent. The
proposed integrated mechanism of adsorption is schematically
represented in Figure 6. This proves that the most suitable
model to describe binding of CF to HA/PLL multilayers is
model C proposed in Figure 1.
According to the schematics in Figure 6, ﬁrst molecules of
CF loaded into the multilayers bind to amino groups of PLL
and do not interact with each other (Figure 6, case 1). This
type of binding is driven through the PLL−CF interaction and
is apparently predominant at a low concentration of CF in
solution (zone a). As CF molecules keep entering the ﬁlm
(zone b), apart from binding to PLL, they interact with each
other. CF molecules that are anchored to the ﬁlm either
strengthen the binding of upcoming CF molecules via a CF−
CF interaction (cooperation, case 2) or act as new binding cites
for CF molecules that are coming from the solution (case 3). At
the same time, there is no clustering of CF molecules to each
other (aggregation), as proven earlier (Figure 2), the
interaction is presumably between two CF molecules. At high
concentrations of CF (zone c), all possible binding sites will be
occupied, resulting in saturation of the multilayers with CF
molecules and reaching a plateau on the adsorption isotherm.
Figure 6 illustrates two extreme cases, where either only the
cooperative mechanism (case 2) or only polyadsorption (case
3) is realized. However, we suppose that both cases take place
simultaneously.
Figure 6. (A) S-shaped isotherm of CF adsorption into HA/PLL multilayers and schematics of CF−PLL and CF−CF interactions in the multilayers
as a function of the CF concentration in solution. (B) Schematic presentation of the PLL backbone interacting with CF molecules. Both ion pairs
and intermolecular CF−CF interactions play a role; however, not all the amino groups can be bound to CF, due to either a sterical factor or the
reduced number of charged amino groups due to the signiﬁcantly lower apparent pKa of PLL in the multilayers compared to that in solution.
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Interestingly, the number of occupied binding sites is less
than the total number of free amino groups of PLL in the
multilayers. One can notice that the molar charge ratio PLL:CF
is about 20 [CF maximum concentration in the multilayers is
13 mM (Figure 5) and the total concentration of amino groups
of PLL is about 250 mM, as we calculated above]. This can be
explained either by sterical factors or the reduced number of
charged amino groups available for interaction with CF in the
multilayers. A sterical factor may mean that the CF−PLL
interaction can only be realized if CF can ﬁnd a PLL amino
group properly oriented in the space to make an ion pair with it
(Figure 6B). One cannot expect signiﬁcant sterical limitations
for CF molecule to reach a backbone of PLL because the HA/
PLL multilayers are highly hydrated (about 80% of water) and
about half (46%) of the amino groups of PLL are unpaired with
HA (free to interact with CF).62 In addition, CF is a small,
compact molecule, allowing free diﬀusion in the hydrated and
bulky multilayers. However, the PLL is a highly ﬂexible
polymer, and it can intertwine, making the access of CF to the
amino groups of PLL diﬃcult.
A limited number of charged amino groups can be another
reason to be considered. The reduced pKa of PLL in HA/PLL
multilayers has been reported.68 Both HA and PLL are
becoming weaker acid and weaker base in the multilayers
compared to their strength in solution. The changes in the pKa
are signiﬁcant and may be a few pH units. The authors68 have
reported that in the multilayers assembled at pH 7.0, HA
changes its pKa from 3.8 to 4.9 and the pKa of PLL is
signiﬁcantly decreased from 9.4 to 6.8. This is related to the
ability of the polymers to change their secondary structure and
increase a degree of conformational order upon adsorption to
the multilayers. At pH 7.0 in the multilayers HA remains still
fully negatively charged (pKa much below 7.0) but the charge
density of PLL can be signiﬁcantly reduced due to its much
lower pKa value in multilayers, i.e., 6.8. This may explain why
CF does not interact with all the available amino groups of PLL
in the multilayer but only with a rather small number of the
groups that still carry a charge. One can speculate that both the
sterical factor and reduction of the apparent pKa of PLL can
play a role.
We believe that the physical−chemical approaches employed
here to understand CF interaction with HA/PLL multilayers
may be helpful to assess the interaction of real drugs with
multilayer ﬁlms and thus open new perspectives to make
advanced biocoatings with tuned loading and release of drugs.
One would expect that some real drugs, such as the anticancer
drug doxorubicin, may possess stronger intermolecular
interaction between drug molecules due to the hydrophobic
nature of the drug and lack of charge. The same approach used
here may be used for doxorubicin loaded into the multilayers.
The aspects of drug or biomolecule (e.g., ATP, doxorubicin)
release from HA/PLL multilayers will be referred to in our
upcoming research.
Understanding the drug−multilayer interaction is a key for
the design of new multilayer-based drug delivery systems,
because this interaction will drive drug release performance.
The proper choice of the multilayer constituents (two or more
polymers such as blend multilayers) will dictate the release rate,
allowing one to get the desired release proﬁle, e.g., burst or
prolonged release or a more complicated proﬁle. In addition,
knowledge of the molecular binding to the multilayers may help
one to engineer free-standing multilayer shells enabling
protective characteristics69 through controlled shell perme-
ability governed by the interaction of molecules from outside
with the capsule shell. We believe that the results of this study
performed at a salt concentration below the physiological salt
concentration will be helpful for the design of novel multilayer-
based drug delivery systems, because the salt concentration in
the multilayers shall be deﬁned by uncompensated charges in
the polymer network of the multilayers if enough salt (to form
counterions) is provided, as in this study. However, interesting
aspects related to the salt concentration inside and outside the
multilayers and the eﬀect salt can have on drug loading/release
will be considered separately in our future research.
■ CONCLUSIONS
In this study we focused on the binding mechanism of the
small, charged dye CF to biopolymer-based multilayers, namely,
(HA/PLL)24 multilayers. CF is a popular ﬂuorescent dye often
used as a model drug. CF can spontaneously be loaded into the
multilayers with a very high partitioning coeﬃcient of about
104, reaching a dye concentration in the ﬁlm of up to 13 mM,
which is much more than the dye solubility in solution (0.5
mM). The CF loading is driven by binding of CF molecules to
free amino groups of PLL in the multilayers. In the multilayers
CF−CF interactions take place but do not dominate over CF−
PLL interactions, giving no aggregates of CF, as found by
analysis of CF ﬂuorescence spectra in the multilayers and in
solution. The binding of CF to multilayers is cooperative, as
indicated by the S-shaped adsorption isotherm. This means that
binding of one CF molecule to the multilayer aﬀects the
binding of another molecule, making the binding of new
coming molecules more favorable. At the same time, anchorage
of CF takes place in accordance with the BET type V
polyadsorption model, meaning that CF molecules that are
stored in the HA/PLL ﬁlm play a role as new binding sites for
new CF molecules. Both mechanisms of adsorption are driven
by CF−CF interactions that enhance the binding aﬃnity and
strengthen the CF−multilayer interaction. Analysis of CF
mobility in the multilayers by FRAP has revealed that more
than 90% of CF molecules diﬀuse very fast (diﬀusion coeﬃcient
D of about 1 μm2/s) and the rest is immobile. As reported in
the literature, mobile PLL has a similar D in the multilayers but
a much higher content of immobile fraction (30−40%).65 On
the basis of this, one can conclude that CF diﬀuses in the
multilayers through both (i) jumping from one amino group to
another (at one or diﬀerent PLL chains) and (ii) diﬀusion
together with PLL chains being bound to the chains. This study
provides new insights into the multilayer−drug interactions
using the model ﬂuorescent dye CF. We believe that the
developed approach and knowledge received can be further
extended and utilized for understanding the mechanism of
loading and release of biologically relevant drugs. Elucidation of
the storage mechanisms would open a new way that would
provide one with knowledge to precisely design tailor-made
multilayers well-suited for applications in drug protection,
separation, and controlled release.
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